Hepatic Venous Outflow Obstruction: Three Similar Syndromes

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2007 Apr 28

PMID 17461490

Citations 43

Authors

Ulas-Darda Bayraktar

Soley Seren

Yusuf Bayraktar

Affiliations

Soon will be listed here.

Abstract

Our goal is to provide a detailed review of veno-occlusive disease (VOD), Budd-Chiari syndrome (BCS), and congestive hepatopathy (CH), all of which results in hepatic venous outflow obstruction. This is the first article in which all three syndromes have been reviewed, enabling the reader to compare the characteristics of these disorders. The histological findings in VOD, BCS, and CH are almost identical: sinusoidal congestion and cell necrosis mostly in perivenular areas of hepatic acini which eventually leads to bridging fibrosis between adjacent central veins. Tender hepatomegaly with jaundice and ascites is common to all three conditions. However, the clinical presentation depends mostly on the extent and rapidity of the outflow obstruction. Although the etiology and treatment are completely different in VOD, BCS, and CH; the similarities in clinical manifestations and liver histology may suggest a common mechanism of hepatic injury and adaptation in response to increased sinusoidal pressure.

Citing Articles

The Association Between Non-Clinically Apparent Liver Fibrosis and Pulmonary Arterial Hypertension in Hispanic Patients.

Kalas M, Khatab Y, Galura G, Alkhateeb H, Mukherjee D, Garcia H Cardiol Res. 2024; 14(6):429-436.

PMID: 38187513 PMC: 10769614. DOI: 10.14740/cr1565.

Successful Transjugular Portosystemic Shunt Treatment of Pediatric Sinusoidal Obstruction: Case Report and Review of Literature.

Ramic L, Speckert M, Ramphal R, Ling S, Temple M, Kehar M JPGN Rep. 2023; 4(4):e355.

PMID: 38034423 PMC: 10684189. DOI: 10.1097/PG9.0000000000000355.

Hepatic Venous Occlusion Type of Budd-Chiari Syndrome versus Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstructive Syndrome: A Multi-Center Retrospective Study.

Tong Y, Zhang M, Qi Z, Wu W, Chen J, He F J Pers Med. 2023; 13(4).

PMID: 37108988 PMC: 10143067. DOI: 10.3390/jpm13040603.

Copy number variation in tRNA isodecoder genes impairs mammalian development and balanced translation.

Hughes L, Rudler D, Siira S, McCubbin T, Raven S, Browne J Nat Commun. 2023; 14(1):2210.

PMID: 37072429 PMC: 10113395. DOI: 10.1038/s41467-023-37843-9.

Study of Morphological Changes in Rat Liver Caused by Occlusion of Inferior Vena Cava.

Tanabayeva S, Almabayev Y, Kamyspaev M, Kulmanbetov R, Kopbayeva M, Akhmad N J Clin Exp Hepatol. 2022; 12(6):1451-1462.

PMID: 36340320 PMC: 9630039. DOI: 10.1016/j.jceh.2022.06.001.

References

Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F . Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol. 1995; 22(1):1-9. DOI: 10.1016/0168-8278(95)80252-5. View

Higashigawa M, Watanabe M, Nishihara H, Tabata N, Azuma E, Ido M . Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1. Leuk Res. 1995; 19(7):477-80. DOI: 10.1016/0145-2126(95)00009-d. View

Hillmen P, Lewis S, Bessler M, Luzzatto L, Dacie J . Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995; 333(19):1253-8. DOI: 10.1056/NEJM199511093331904. View

Wang Z, Jones R . Budd-Chiari syndrome. Curr Probl Surg. 1996; 33(2):83-211. DOI: 10.1016/s0011-3840(96)80001-3. View

Or R, Nagler A, Shpilberg O, Elad S, Naparstek E, Kapelushnik J . Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. Transplantation. 1996; 61(7):1067-71. DOI: 10.1097/00007890-199604150-00014. View

DeLeve L, Wang X, Kuhlenkamp J, Kaplowitz N . Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology. 1996; 23(3):589-99. DOI: 10.1002/hep.510230326. View

Xu K, He F, Zhang H, Zhang X, Han M, Wang C . Budd-Chiari syndrome caused by obstruction of the hepatic inferior vena cava: immediate and 2-year treatment results of transluminal angioplasty and metallic stent placement. Cardiovasc Intervent Radiol. 1996; 19(1):32-6. DOI: 10.1007/BF02560144. View

Shrestha S, Okuda K, Uchida T, Maharjan K, Shrestha S, Joshi B . Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol. 1996; 11(2):170-9. DOI: 10.1111/j.1440-1746.1996.tb00056.x. View

Raju G, Felver M, Olin J, Satti S . Thrombolysis for acute Budd-Chiari syndrome: case report and literature review. Am J Gastroenterol. 1996; 91(6):1262-3. View

10.

Rozman C, Carreras E, Qian C, Gale R, BORTIN M, Rowlings P . Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant. 1996; 17(1):75-80. View

11.

Mahmoud A, Mendoza A, Meshikhes A, Olliff S, West R, Neuberger J . Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM. 1996; 89(1):37-43. DOI: 10.1093/oxfordjournals.qjmed.a030135. View

12.

Sebagh M, Debette M, Samuel D, Emile J, Falissard B, Cailliez V . "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection. Hepatology. 1999; 30(5):1144-50. DOI: 10.1002/hep.510300514. View

13.

Mertens R, Brost H, Granzen B, Nowak-Gottl U . Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer. Eur J Pediatr. 2000; 158 Suppl 3:S154-8. DOI: 10.1007/pl00014344. View

14.

Wang X, Kanel G, DeLeve L . Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology. 2000; 31(2):428-34. DOI: 10.1002/hep.510310224. View

15.

Denninger M, Chait Y, Casadevall N, Hillaire S, Guillin M, Bezeaud A . Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000; 31(3):587-91. DOI: 10.1002/hep.510310307. View

16.

Olzinski A, Sanyal A . Treating Budd-Chiari Syndrome: making rational choices from a myriad of options. J Clin Gastroenterol. 2000; 30(2):155-61. DOI: 10.1097/00004836-200003000-00007. View

17.

Azoulay D, Castaing D, Lemoine A, Hargreaves G, Bismuth H . Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transplant. 2000; 25(9):987-92. DOI: 10.1038/sj.bmt.1702386. View

18.

Ringden O, Remberger M, Lehmann S, Hentschke P, Mattsson J, Klaesson S . N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation. Bone Marrow Transplant. 2000; 25(9):993-6. DOI: 10.1038/sj.bmt.1702387. View

19.

Okuda K . Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis. 2002; 22(1):15-26. DOI: 10.1055/s-2002-23203. View

20.

DeLeve L, Shulman H, McDonald G . Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis. 2002; 22(1):27-42. DOI: 10.1055/s-2002-23204. View